UniSuper Management Pty Ltd Purchases 5,795 Shares of Teradyne, Inc. (NASDAQ:TER)

UniSuper Management Pty Ltd increased its holdings in shares of Teradyne, Inc. (NASDAQ:TERFree Report) by 16.7% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 40,406 shares of the company’s stock after purchasing an additional 5,795 shares during the period. UniSuper Management Pty Ltd’s holdings in Teradyne were worth $5,088,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the business. Van ECK Associates Corp boosted its stake in shares of Teradyne by 59.9% during the 4th quarter. Van ECK Associates Corp now owns 4,928,143 shares of the company’s stock worth $620,552,000 after acquiring an additional 1,846,079 shares during the period. Proficio Capital Partners LLC bought a new position in Teradyne during the fourth quarter worth $12,118,000. Cerity Partners LLC boosted its position in Teradyne by 87.1% during the third quarter. Cerity Partners LLC now owns 11,371 shares of the company’s stock worth $1,523,000 after purchasing an additional 5,294 shares during the period. Nomura Asset Management Co. Ltd. increased its holdings in shares of Teradyne by 17.6% in the third quarter. Nomura Asset Management Co. Ltd. now owns 77,092 shares of the company’s stock valued at $10,325,000 after purchasing an additional 11,541 shares during the last quarter. Finally, Franklin Resources Inc. raised its position in shares of Teradyne by 30.5% in the third quarter. Franklin Resources Inc. now owns 88,879 shares of the company’s stock valued at $11,878,000 after purchasing an additional 20,762 shares during the period. Institutional investors and hedge funds own 99.77% of the company’s stock.

Insiders Place Their Bets

In other Teradyne news, CFO Sanjay Mehta sold 614 shares of the business’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $102.00, for a total transaction of $62,628.00. Following the sale, the chief financial officer now owns 30,446 shares of the company’s stock, valued at approximately $3,105,492. The trade was a 1.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Ryan Driscoll sold 437 shares of the stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $102.00, for a total value of $44,574.00. Following the completion of the transaction, the vice president now owns 4,312 shares of the company’s stock, valued at $439,824. The trade was a 9.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 8,479 shares of company stock valued at $1,013,134. 0.18% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

TER has been the topic of a number of research reports. UBS Group set a $130.00 price target on shares of Teradyne and gave the company a “buy” rating in a research note on Wednesday, March 12th. Vertical Research started coverage on Teradyne in a research report on Friday, March 7th. They issued a “buy” rating and a $135.00 target price on the stock. TD Cowen lowered their target price on Teradyne from $135.00 to $110.00 and set a “buy” rating on the stock in a research note on Wednesday, March 12th. Citigroup decreased their price objective on Teradyne from $130.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, March 12th. Finally, Morgan Stanley dropped their target price on Teradyne from $112.00 to $81.00 and set an “underweight” rating for the company in a report on Friday, March 14th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $121.44.

Read Our Latest Analysis on TER

Teradyne Trading Down 3.4 %

NASDAQ TER opened at $82.78 on Friday. The firm’s 50 day simple moving average is $107.90 and its 200 day simple moving average is $117.48. The firm has a market capitalization of $13.39 billion, a price-to-earnings ratio of 24.86, a P/E/G ratio of 2.83 and a beta of 1.46. Teradyne, Inc. has a 1 year low of $82.47 and a 1 year high of $163.21.

Teradyne (NASDAQ:TERGet Free Report) last issued its earnings results on Wednesday, January 29th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. Teradyne had a return on equity of 19.08% and a net margin of 19.23%. On average, equities research analysts forecast that Teradyne, Inc. will post 3.88 earnings per share for the current year.

Teradyne Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 14th were paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 0.58%. The ex-dividend date of this dividend was Friday, February 14th. Teradyne’s payout ratio is 14.41%.

Teradyne Profile

(Free Report)

Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.

Further Reading

Want to see what other hedge funds are holding TER? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teradyne, Inc. (NASDAQ:TERFree Report).

Institutional Ownership by Quarter for Teradyne (NASDAQ:TER)

Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.